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The histopathology of herpes simplex encephalitis (HSE) has been described principally
from postmortem studies which reveal end-stage disease. Biopsy material, which selects an
earlier stage in disease development, has been used principally to isolate virus, identify viral
particles, and locate viral antigens. Further, little attention has been paid to the histopathology
of biopsies of encephalitis of undefined etiology. In the present study, sections from biopsies
which yielded virus and those which were negative for virus were evaluated in a systematic and
controlled manner. Biopsies yielding virus were characterized by meningeal inflammation,
perivascular infiltrates, and glial nodules. Biopsies which did not yield virus and which failed
to reveal another diagnosis were characterized by nonspecific gliosis. Thus the early histio-
pathology of HSE is characterized by early signs of inflammation in the absence of necrosis
and generally differs from biopsies in which virus is not isolated.
The pathology of herpes simplex encephalitis (HSE) has been most extensively
studied in postmortem material [1]. Postmortem material, however, represents an
end-point in the evolution of the disease. It would be of interest to analyze the
histopathological changes early in the course of proven human herpes simplex virus
(HSV) infection. Such a study gains importance from the need to make therapeutic
decisions in the course of a suspected HSE [2]. The practice of obtaining brain bi-
opsy prior to the initiation of antiviral therapy affords the opportunity to compare
the histopathology of virologically proven HSE early in the disease with that in
which no agent is isolated. In order to compare the histopathological characteristics
ofviral-positive specimens with those from which no virus was isolated, we collected
cases which were biopsied for the possibility of HSE. The histologic sections were
evaluated with standardized criteria but without knowledge of whether the biopsies
yielded HSV. Subsequently the results were grouped into viral-positive and viral-
negative categories and the observations analyzed.
PATIENTS AND METHODS
Patients
Cases biopsied for focal encephalitis in a period of 78 months at the West Haven
VA Medical Center and the Yale-New Haven Hospital were reviewed. The medical
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All rights of reproduction in any form reserved.records ofthese patients were reviewed for clinical, laboratory, and neurodiagnostic
test characteristics. Various neurodiagnostic tests were used. These included the
electroencephalogram, isotope brain scan, computerized tomography, and angiog-
raphy. Histopathologic biopsy material was available for review (as discussed later)
for 12 of the 14 identified patients. Of the 12 patients, five had virus-positive biop-
sies. Two patients whose biopsies were negative were later shown by other studies to
have had HSE. One had autopsy-confirmed viral isolation [2] whereas the other pa-
tient developed a diagnostic level of CSF anti-HSV antibody.
Histopathologic Studies
Routine sections of formalin-fixed, paraffin-embedded, and hematoxylin- and
eosin- (H and E) stained biopsy specimens were reviewed for the 12 cases. Sections
with special stains were reviewed when available. In the current study, however,
these stains contributed no information beyond that obtained with routine H and E
stained sections. The sections were read without the benefit ofclinical or virological
data. Changes in both gray and white matter as well as the meninges were evaluated
for each case (Table 2). After the standardized evaluation, an overall diagnostic im-
pression was rendered. Subsequently the readings were assigned to the appropriate




Cases with HSV positive and negative biopsies analyzed retrospectively revealed
no discriminative clinical differences (Table 1). Symptoms, signs, or abnormalities
in neurodiagnostic tests referable to temporal or adjacent parietal or frontal lobes
were present in all patients. Fever prior to biopsy was also found in all patients. CSF
pleocytosis was found in all but one, an HSE proven patient. Localization by
neurodiagnostic test was obtained in six of seven patients with proven HSE and in
three of five patients negative for HSE. Of these tests, the pre-biopsy EEG was
localizing in five positive cases and in two negative cases. Two of the positive cases
demonstrated periodic discharges before biopsy.
Histopathological Findings
The sections from all cases were read in the absence of clinical and virological
data. Of the 12 cases selected for study, five yielded HSV from the biopsy whereas
TABLE 1
Clinical Characteristics of Patients Biopsied for Herpes Simplex Encephalitis
Focality on
HSV Clinical CSF Neurodiagnostic
Isolation Focality Fever Pleocytosis Testa
Positive 5/5b 5/5 4/5 4/5
Negativec 5/7 7/7 7/7 5/7
aElectroencephalogram, isotope brain scan, computerized axial tomography, an-
giography
"Number positive/Number tested
cContains two cases shown to be HSE by other evidence (one by virus isolation at
autopsy, one by CSF antibody studies)
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TABLE 2
Histopathological Characteristics of Biopsies Taken for Suspected Herpes Simplex Encephalitis
Gliosis PVIb
HSV Meningeal Glial
Isolation Infiltrate G- W G W Nodules Inclusions Diagnosis
Positive 4/4c 5/5 5/5 4/5 5/5 3/5 1/5 4/5 Encephalitis
Negative 2/6 7/7 6/6 2/7 2/7 0/7 0/7 5/7 Gliosis
aG = Gray matter, W = White matter
bPerivascular infiltrate
cNumber tested/Number in which assessment possible
seven did not. The histopathological findings are shown in Table 2. Non-specific
reactive gliosis was found in white and gray matter in all HSV positive and negative
biopsies. However, signs of inflammation were found predominantly in biopsies
which yielded HSV. Thus, meningeal infiltrates were found in all positive biopsies
which included portions ofmeninges. Perivascular infiltrates were found in negative
as well as positive biopsies; however, in positive biopsies they were more frequently
found in both gray and white matter. Glial nodules were found only in positive biop-
sies. Intranuclear inclusion bodies were found in one virus-positive biopsy. In the
two cases in which the biopsies were negative for virus but which were shown by
autopsy or CSF antibody studies to be HSE, no inflammation was found in the
biopsies. Four of the five virus-positive specimens were histopathologically diag-
nosed as encephalitis, whereas only oneofseven ofthe virus-negative specimens was
diagnosed as encephalitis (Table 2). No etiology was found in the one negative case
histopathologically diagnosed as encephalitis.
DISCUSSION
The present study appears to be the first controlled evaluation of the histopa-
thology in biopsies from patients with suspected HSE. Originally the histopathology
of HSE had been established in autopsy material by Haymaker [1]. More recently
Nahmias et al. reported that 85 percent of HSV positive biopsies were histopatho-
logically diagnosed as encephalitis whereas only 36 percent ofHSV negative biopsies
were diagnosed as encephalitis [3]. However, the incidence ofthe individual charac-
teristics ofthe histopathology were not given. In addition, thehistology was not per-
formed in a controlled fashion. In the present study the histopathologist was denied
access to the clinical and virological data associated with the histological sections.
Specific characteristics and a diagnostic impression were noted. Four of five HSV
positive biopsies were scored as encephalitis. These were associated with meningeal
inflammation, perivascular infiltration, and glial nodules. Inclusions were found in
one case. Necrosis and hemorrhage were not part of the pathology. In the virus-
negative group one was evaluated as encephalitis and another was read as stroke.
However, the five remaining biopsies revealed only nonspecific gliosis.
Autopsy studies have tended to demonstrate rather severe histopathological
changes. Necrosis characterized portions of the cortex of each of the three cases
reported by Haymaker [1]. Large mononuclear and compound granular cells were
found to replace superficial cortical laminae. Perivascular infiltrates and neuron-
ophagic nodules were also described. In an elegant immunoperoxidase study of
HSE by Esiri the cases came to autopsy from four days to three years after the onset
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of neurological signs are the most comparable to cases biopsied in the course of
management of suspected HSE. Signs of inflammation were scanty and seen as
perivascular cuffs in the meninges and superficial cortex. In these patients viral an-
tigen was found in both hemispheres, with slightly more on the more affected side.
Inflammation and necrosis was found to peak in the third week, at which time viral
antigen was declining. Our findings in this biopsy study correspond to those found
by Esiri in the first week of neurological dysfunction. Meningeal and perivascular
infiltrates were found but necrosis was not found in biopsies which yielded HSV.
Comparison of isolation-positive versus isolation-negative biopsies in the Na-
tional Collaborative Study revealed a morphologic diagnosis of encephalitis in 85
percent of positive cases [3]. Four of the five virus-positive biopsies in the present
series were read "blindly" as encephalitis. In the National Collaborative Study 56
percent ofHSV positive biopsies and 14 percent of HSV negative biopsies contained
intranuclear inclusions. In the present series only one case was found to contain
intranuclear inclusions. Although Haymaker required inclusions as well as the isola-
tion of HSV for the diagnosis of HSE [1], it is clear that the observation of inclu-
sions is inconsistent. In a study of ten cases of HSE, White and Taxy found inclu-
sions to be absent in one, rare in six, and numerous in three [5]. In addition the type
of fixative influences their visualization; Bouin's fixative facilitates their identifica-
tion. Thus, while the observation of intranuclear inclusions is useful, it is neither
consistent nor diagnostic and is technically variable.
Considerable interest attaches to the group of biopsies from which virus was not
isolated. Of paramount therapeutic importance is the category of other processes
which can mimic HSE. In the National Collaborative Study, other infections, in-
cluding several other viral infections, vascular disease, and tumors were found [6].
In the present group negative for virus isolation one case ofvascular disease and one
case histopathologically identified as encephalitis were found. Another category are
those biopsies which fail to yield HSV but in which HSE can be diagnosed by other
means. In the present series one case had HSV isolated at autopsy (previously
reported [2]), and another was shown to be HSE by the development of antibody in
the CSF. Each of these cases demonstrated only nonspecific gliosis on histo-
pathological examination of the biopsy specimens. There remain the biopsies from
which virus is not isolated, in which the histopathology does not yield an alternative
diagnosis, and in which a diagnosis is not reached by other tests. Clinically they
would be termed encephalitis of undetermined etiology. Three such biopsies are in
the present series. The histopathology in each ofthese cases was read as nonspecific
gliosis. On occasion this type ofbiopsy will be obtained in HSE in which the appro-
priate sampling was not achieved. However, this is a group in which other etiologies
must be sought by careful epidemiologic, immunologic, and immunohistological
studies.
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